BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10468865)

  • 21. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
    Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
    Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Frequency of cytotoxic and helper T-lymphocyte precursors in donors with alloreactivity to recipient histocompatibility antigens. Possible use in predicting acute graft vs host disease in bone marrow transplantation].
    Cukrová V; Dolezalová L; Loudová M; Vítek A; Starý J
    Cas Lek Cesk; 1997 Feb; 136(3):80-4. PubMed ID: 9221174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.
    Qayed M; Wang T; Hemmer MT; Spellman S; Arora M; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Aljurf M; Ayas M; Bitan M; Cairo M; Choi SW; Dandoy C; Delgado D; Gale RP; Hale G; Frangoul H; Kamble RT; Kharfan-Dabaja M; Lehman L; Levine J; MacMillan M; Marks DI; Nishihori T; Olsson RF; Hematti P; Ringden O; Saad A; Satwani P; Savani BN; Schultz KR; Seo S; Shenoy S; Waller EK; Yu L; Horowitz MM; Horan J
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):521-528. PubMed ID: 29155316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histocompatibility and bone marrow transplantation (BMT).
    Richter KV
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):445-50. PubMed ID: 2480287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation.
    Hattori H; Matsuzaki A; Suminoe A; Ihara K; Nagatoshi Y; Sakata N; Kawa K; Okamura J; Hara T
    Bone Marrow Transplant; 2002 Nov; 30(10):665-71. PubMed ID: 12420205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high percentage of HLA-DQ+ and HLA-DR+ mononuclear cells is associated with a low incidence of acute graft-versus-host disease after allogeneic bone marrow transplantation (BMT) in children.
    Garin L; Rigal D; el Marsafy S; Bernaud J; Philippe N; Souillet G
    Clin Exp Immunol; 1994 May; 96(2):344-9. PubMed ID: 8187344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors.
    Martin P; Bleyzac N; Souillet G; Galambrun C; Bertrand Y; Maire PH; Jelliffe RW; Aulagner G
    Bone Marrow Transplant; 2003 Nov; 32(9):881-7. PubMed ID: 14561988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of unrelated-donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study.
    Bradley BA; Hows JM; Gore SM; Bidwell JL; Clay T; Downie TR; Gluckman E; Howard MR; Laundy GJ
    Clin Transpl; 1992; ():91-107. PubMed ID: 1306726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are HLA antigens a risk factor for acute GVHD in thalassemic patients receiving HLA-identical stem cell transplantation?
    Mohyeddin Bonab M; Alimoghaddam K; Vatandoust S; Forouzia F; Jahani M; Ghavamzadeh A
    Transplant Proc; 2004 Dec; 36(10):3190-3. PubMed ID: 15686726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
    El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
    Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation.
    Loiseau P; Espérou H; Busson M; Sghiri R; Tamouza R; Hilarius M; Raffoux C; Devergie A; Ribaud P; Socié G; Gluckman E; Charron D
    Bone Marrow Transplant; 2002 Oct; 30(8):497-502. PubMed ID: 12379888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the adhesion molecule CD31 act as a minor histocompatibility antigen?
    Da Costa L; Charron D; Loiseau P
    Blood; 1997 Aug; 90(3):1332. PubMed ID: 9242570
    [No Abstract]   [Full Text] [Related]  

  • 35. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
    Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-DP and allogeneic bone marrow transplantation.
    Moreau P; Cesbron A
    Bone Marrow Transplant; 1994 Jun; 13(6):675-81. PubMed ID: 7920290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.
    Anasetti C; Amos D; Beatty PG; Appelbaum FR; Bensinger W; Buckner CD; Clift R; Doney K; Martin PJ; Mickelson E
    N Engl J Med; 1989 Jan; 320(4):197-204. PubMed ID: 2643045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.